ERBB2 and breast carcinoma: Furthermore, the results of the present study suggest no long-term independent association with Ki-67 status among patients with lymph node–negative, ER-positive/ERBB2-negative breast cancer, and Ki-67 status was found to have only moderate estimation value in Pan et al4 (data on Ki-67 status were available for 12% of patients).